CSIMarket


Nature s Sunshine Products inc   (NATR)
Other Ticker:  
 

Nature s Sunshine Products inc

NATR's Fundamental analysis








Looking into Nature S Sunshine Products Inc growth rates, revenue grew by 7.67 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 1063

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Nature S Sunshine Products Inc 's net income grew by 348.37 % in IV. Quarter 2023 year on year, above company average,

More on NATR's Growth


Nature S Sunshine Products Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Nature S Sunshine Products Inc PEG ratio is at -0.01 Company is currently trading with Price to Cash flow multiple of 16.39 in trailing twelve-month period.
Company
24.08
PE TTM   
Industry
360.97
PE TTM    
Company's Price to Sales ratio is at 0.82.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.34.


More on NATR's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 211,965
 Net Income/Employee (TTM) $ 7,817
 Receivable Turnover (TTM) 43.15
 Tangible Book Value (Per Share $) 8.15

Nature S Sunshine Products Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Nature S Sunshine Products Inc PEG ratio is at -0.01 Company is currently trading with Price to Cash flow multiple of 16.39 in trailing twelve-month period.
Company
24.08
PE TTM   
Industry
360.97
PE TTM    
Company's Price to Sales ratio is at 0.82.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.34.

Nature S Sunshine Products Inc Price to Book Ratio is at 2.29 lower than Indusry Avg. of 1523.92. and higher than S&P 500 Avg. of 0.01

More on NATR's Valuation

  Market Capitalization (Millions $) 366
  Shares Outstanding (Millions) 20
  Employees 2,100
  Revenues (TTM) (Millions $) 445
  Net Income (TTM) (Millions $) 16
  Cash Flow (TTM) (Millions $) 22
  Capital Exp. (TTM) (Millions $) -10
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 211,965
  Net Income/Employee(TTM) $ 7,817
  Receivable Turnover Ratio (TTM) 43.15
  Tangible Book Value (Per Share $) 8.15

  Market Capitalization (Millions $) 366
  Shares Outstanding (Millions) 20
  Employees 2,100
  Revenues (TTM) (Millions $) 445
  Net Income (TTM) (Millions $) 16
  Cash Flow (TTM) (Millions $) 22
  Capital Exp. (TTM) (Millions $) -10


    NATR's Profitability Comparisons
Nature S Sunshine Products Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 5.16 % from 5.29 % in III. Quarter.

Nature S Sunshine Products Inc net profit margin of 8.45 % is currently ranking no. 37 in Major Pharmaceutical Preparations industry, ranking no. 113 in Healthcare sector and number 1300 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.16
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.6
  Asset Turnover Ratio (TTM) 1.93
  Inventory Turnover Ratio (TTM) 1.86



Nature S Sunshine Products Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 5.16 % from 5.29 % in III. Quarter.

Nature S Sunshine Products Inc net profit margin of 8.45 % is currently ranking no. 37 in Major Pharmaceutical Preparations industry, ranking no. 113 in Healthcare sector and number 1300 in S&P 500.

More on NATR's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com